Artia Global Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.38M Buy
+18,437
New +$3.4M 0.68% 29
2023
Q3
Sell
-52,275
Closed -$14.9M 29
2023
Q2
$14.9M Sell
52,275
-27,725
-35% -$8.25M 5.13% 4
2023
Q1
$22.2M Buy
80,000
+50,000
+167% +$13.8M 8.22% 3
2022
Q4
$8.31M Buy
+30,000
New +$8.47M 3.17% 9

Other funds holding BIIB

Artia Global Partners's BIIB Position: Q1 2026 in Review

Artia Global Partners opened a new position in Biogen (BIIB) in Q1 2026: 18,437 shares worth $3.38M. The stake represents 0.68% of the portfolio and ranks #29 among its holdings. This is a return to the name: Artia Global Partners previously reported a position in BIIB as recently as Q2 2023.

Artia Global Partners first reported a position in BIIB in Q4 2022 and has held it in 4 quarters since. The position peaked at $22.2M in Q1 2023. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Artia Global Partners held 18,437 shares of Biogen worth $3.38M as of Q1 2026.
  • Biogen was a new Artia Global Partners position in Q1 2026.
  • Biogen made up 0.68% of Artia Global Partners's portfolio in Q1 2026, its #29 holding.
  • Artia Global Partners first reported a position in Biogen in Q4 2022 and has held it in 4 quarters since.
  • Artia Global Partners's Biogen position peaked at $22.2M in Q1 2023.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.